No Change Seen in Frequency of Recurrent Vertigo Attacks Over Time
Medically reviewed by Drugs.com.
By Lori Solomon HealthDay Reporter
THURSDAY, Sept. 7, 2023 -- Among people with benign recurrent vertigo (BRV), Meniere disease (MD), or vestibular migraine (VM) who have persistent vertigo attacks, there is no change in attack frequency over time, according to a study published online Aug. 11 in Audiology and Neurotology.
Maarten C. Uijttewaal, from Gelre Hospitals in the Netherlands, and colleagues explored changes in the duration and trigger factors of vertigo attacks in 117 patients with BRV, MD, or VM followed for three years.
The researchers found that 48.7 percent of patients kept reporting vertigo attacks at one or more follow-ups. Compared with baseline, no diagnosis groups showed significant shortening of attack duration during follow-up. Reports of stress and fatigue as triggers for attacks differed significantly between the three groups at baseline (stress: BRV, 40.9 percent; MD, 62.8 percent; VM, 76.5 percent; P = 0.005; fatigue: BRV, 31.0 percent; MD, 48.8 percent; VM, 68.8 percent; P = 0.003). A consistent reduction in stress and fatigue as triggers was seen in the VM group until the 24- and 30-month follow-up measurements, respectively (odds ratios [ORs], 0.15 to 0.33; P < 0.05). A consistent reduction of head movements as a trigger was seen in the MD group at the 24-month measurement onward (ORs, 0.07 to 0.11; P < 0.05).
“Our findings suggest that despite the decrease in the number of patients still experiencing vertigo attacks in all three diagnosis groups, no shortening of the duration of the attacks was observed in patients who continued to have attacks during the three-year follow-up,” the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted September 2023
Read this next
Triple Semicircular Canal Occlusion + Endolymphatic Sac Decompression Alleviates Vertigo
WEDNESDAY, June 5, 2024 -- Triple semicircular canal occlusion combined with endolymphatic sac decompression (ESD) may be an effective treatment option for managing frequent...
Cochlear Implants Aid Meniere Disease Outcomes
TUESDAY, June 4, 2024 -- Cochlear implantation (CI) positively impacts hearing, vertigo, tinnitus, and quality of life in patients with Meniere disease (MD), according to a study...
No Causal Association Seen for Meniere Disease, Migraine
MONDAY, June 3, 2024 -- Migraine is not a risk factor for Meniere disease (MD), nor is MD a risk factor for migraine, according to a study published online May 8 in Frontiers in...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.